ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Lyme Disease Diagnostics Market Industry Analysis 2021, Featuring Key Players T2 Biosystems, Inc., Bio-Rad Laboratories, DiaSorin S.p.A. and Lyme Diagnostics Ltd. - ResearchAndMarkets.com

October 4, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Oct 4, 2021--

The “Lyme Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.

This report on the global Lyme disease diagnostic market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global Lyme disease diagnostic market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Lyme disease diagnostic market from 2021 to 2031.

ADVERTISEMENT

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global Lyme disease diagnostic market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Lyme disease diagnostic market.

The report delves into the competitive landscape of the global Lyme disease diagnostic market. Key players operating in the global Lyme disease diagnostic market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Lyme disease diagnostic market profiled in this report.

Key Questions Answered in the Report

  • What is the sales/revenue generated by Lyme disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global Lyme disease diagnostic market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which diagnostic test segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

     

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

5. Market Outlook

ADVERTISEMENT

6. Global Lyme Disease Diagnostics Market Analysis, by Diagnostic Test

7. Global Lyme Disease Diagnostics Market Analysis, by Sample

8. Global Lyme Disease Diagnostics Market Analysis, by End-user

9. Global Lyme Disease Diagnostics Market Analysis, by Region

10. North America Lyme Disease Diagnostics Market Analysis

11. Europe Lyme Disease Diagnostics Market Analysis

12. Asia Pacific Lyme Disease Diagnostics Market Analysis

13. Latin America Lyme Disease Diagnostics Market Analysis

14. Middle East & Africa Lyme Disease Diagnostics Market Analysis

15. Competition Landscape

  • T2 Biosystems, Inc.
  • QIAGEN
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech plc
  • IGeneX, Inc.
  • Lyme Diagnostics Ltd.
  • PerkinElmer, Inc.
  • Oxford Immunotec plc (Boulder Diagnostics)
  • Cenogenics Corporation
  • Quest Diagnostics
  • Ceres Nanosciences, Inc.
  • Galaxy Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/6p67pl

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20211004005804/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 10/04/2021 01:06 PM/DISC: 10/04/2021 01:07 PM

http://www.businesswire.com/news/home/20211004005804/en